Resource hub
Key outcomes and insights from the consortium’s work, driving innovation in medicine development for rare and paediatric diseases.
Explore the progress of the ERAMET project in our Results section. Here we showcase key outcomes and insights from our consortium’s work, driving innovation in medicine development for rare and paediatric diseases.
This section is updated regularly with contributions from our partners, highlighting milestones, achievements and project impact. Return often to track our progress, or subscribe to the newsletter to be notified of new deliverables.
Outputs
A new publication in Clinical Pharmacology & Therapeutics highlights how innovative model-informed approaches can support more efficient evidence g…
Francesco Pappalardo, from the University of Catania, presented ERAMET as a concrete example of an ecosystem supporting pediatric rare disease rese…
Assessment and Benchmarking of Model Informed Approaches in Drug Development for Hemoglobinopathies: A Review of Scientific Advices From January 20…
Advancing Paediatric Drug Development Through Optimised Study Design We are pleased to highlight a new scientific publication by Phanio Djokoto, no…
A new article has been published in Clinical and Translational Science, titled: AI-Driven Applications in Clinical Pharmacology and Translational S…
